BeiGene, Ltd.
ONC
$230.98
$2.841.25%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | 23.43% | 12.11% | 70.75% | 59.96% | 56.84% |
Total Depreciation and Amortization | 100.87% | 401.39% | 23.79% | 33.14% | 32.64% |
Total Amortization of Deferred Charges | 28.17% | 392.53% | 38.13% | 28.78% | 15.56% |
Total Other Non-Cash Items | 4,669.03% | 573.13% | -88.85% | -91.95% | -96.61% |
Change in Net Operating Assets | 55.83% | -16,833.02% | 26.38% | 17.90% | -378.04% |
Cash from Operations | 86.46% | 37.50% | 60.78% | 51.76% | 24.16% |
Capital Expenditure | 8.16% | 0.69% | -19.56% | -43.36% | -69.28% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -109.12% | -111.12% | -101.01% | -88.08% | -57.20% |
Cash from Investing | -1,236.02% | -252.93% | -212.28% | -136.25% | -95.42% |
Total Debt Issued | 37.79% | 168.08% | 82.12% | 177.31% | 94.80% |
Total Debt Repaid | 14.79% | 62.86% | -181.33% | -123.37% | -123.23% |
Issuance of Common Stock | 10.74% | 2.86% | 140.32% | 124.69% | 254.75% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | 6.81% | 6.81% | -- | -- | -- |
Other Financing Activities | -21.67% | -7.47% | -- | -- | -- |
Cash from Financing | -51.67% | 817.60% | 190.70% | 2,264.56% | 2,285.71% |
Foreign Exchange rate Adjustments | -567.69% | -123.38% | 129.97% | 38.00% | 88.71% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 16.58% | -22.01% | 28.76% | 10.42% | -33.69% |